ArticleAmerican journal of respiratory and critical care medicine2024
Digital Spatial Profiling Identifies Distinct Molecular Signatures of Vascular Lesions in Pulmonary Arterial Hypertension.
Erratum issuedOpen access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 35 citations in OpenAlex.
- Heterogeneous nuclear ribonucleoprotein A1 as a candidate associated with pulmonary vascular remodeling in pulmonary arterial hypertension.Journal of molecular and cellular cardiology plus · 2026Article
- Ambient PMEnvironment & health (Washington, D.C.) · 2026Article
- Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension.American journal of respiratory and critical care medicine · 2026Article
- Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responses.Journal of advanced research · 2026Article
- The bile acid-oxysterol axis in pulmonary arterial hypertension: from sterol trafficking to precision phenotyping and therapeutic opportunities.Molecular biology reports · 2026Review
- KLF6 activation marks an angiogenic and apoptosis resistant endothelial phenotype in pulmonary arterial hypertension.Communications biology · 2026Article
- The right time, the right cell: the potential for precision senotherapy in pulmonary arterial hypertension.American journal of physiology. Lung cellular and molecular physiology · 2026Review
- Adventitial Niches, Complement and Inflammation in Pulmonary Vascular Disease: Current Status and Future Directions.Comprehensive Physiology · 2026Review
- Multi-Omic and Single-Cell Approaches for Elucidating Cell Biology and Pathobiology of Lung Disease.American journal of respiratory cell and molecular biology · 2026Review
- Multi-omics integration study of vascular smooth muscle cell phenotypic conversion identified novel biomarkers in idiopathic pulmonary arterial hypertension.Respiratory research · 2026Article
- Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.Frontiers in immunology · 2026Article
- Multifaceted mechanisms of plant metabolites in pulmonary arterial hypertension: a critical review beyond vasodilation.Frontiers in pharmacology · 2026Review
- Endothelial Heterogeneity in Pulmonary Hypertension.Arteriosclerosis, thrombosis, and vascular biology · 2026Review
- Pericytes and Lung Vascular Remodeling.Arteriosclerosis, thrombosis, and vascular biology · 2026Review
- Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target.International journal of molecular sciences · 2025Review
- A Lifelong Journey in the Field of the Pulmonary Circulation: Perspectives Through the Lens of the Cardiovascular Pulmonary Research Laboratory.Pulmonary circulation · 2025Article
- Macrophage ferroptosis potentiates GCN2 deficiency induced pulmonary venous arterialization.Nature communications · 2025Article
- SETD2 drives METTL14-mediated mCellular and molecular life sciences : CMLS · 2025Article
- Lung endothelial cell heterogeneity in health and pulmonary vascular disease.American journal of physiology. Lung cellular and molecular physiology · 2025Review
- Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia.American journal of physiology. Lung cellular and molecular physiology · 2025Article
Corrections and comments
- Commented on by
- Erratum issued
Authors and funding
11 authors at 5 institutions in 2 countries.
Rubin M TuderCardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Department of Medicine.
Aneta GandjevaCardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Department of Medicine.
Sarah WilliamsQueensland Cyber Infrastructure Foundation, St. Lucia, Queensland, Australia.
Sushil KumarCardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Department of Medicine.
Vitaly O KheyfetsProgram in Translational Lung Research, Division of Pulmonary and Critical Care Sciences, Department of Medicine.
Kyle Matthew Hatton-JonesMenzies Health Institute, and.
Jacqueline R StarrChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and.
Jeong YunChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and.
Jason HongDivision of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
Nicholas P WestMenzies Health Institute, and.
Kurt R StenmarkCardiovascular Pulmonary Research Laboratories, Department of Pediatrics and Department of Medicine.
Pulmonary Associates · USGriffith University · AUBrigham and Women's Hospital · USUniversity of California, Los Angeles · USUniversity of Colorado Anschutz Medical Campus · US
Funding
Harvard Clinical and Translational Science CenterUM1TR004408 · NCATS · HARVARD MEDICAL SCHOOL · PI Lindsey Robert Baden, Lee Marshall Nadler · 2023 to 2026
$43.3MVRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1MRole of Complement-Driven Pulmonary Vascular Inflammation in PHP01HL152961 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DELANEY, CASSIDY A · 2020 to 2024
$14.1MBayesian multivariate 3D spatial modeling for microbiome image analysisR01GM126257 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, KYU HA, STARR, JACQUELINE R · 2021 to 2024
$2.4MThe role of COPD genetic risk factor HHIP on lymphocytic inflammationK08HL146972 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI YUN, JEONG H · 2020 to 2024
$848kIntegrative Multiomics to Uncover Novel Genes and Networks in Pulmonary Arterial HypertensionK08HL169982 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Jason Hong · 2023 to 2026
$706kNCATS NIH HHS UM1 TR004408NHLBI NIH HHS K08 HL146972NHLBI NIH HHS K08 HL169982NHLBI NIH HHS P01 HL014985NHLBI NIH HHS P01 HL152961NIGMS NIH HHS R01 GM126257NIH HHS K08HL146972NIH HHS UM1TR004408
Abstract
PubMed holds no abstract for this paper.
Indexed as
Pulmonary ArteryAdultFamilial Primary Pulmonary HypertensionFemaleGene Expression ProfilingHumansMaleMiddle AgedPulmonary Arterial HypertensionTranscriptomeVascular Remodelingcomplementdigital spatial transcriptomic profilinghypoxiainflammationpulmonary hypertension
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.